Charles Schwab Investment Management Inc. Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Charles Schwab Investment Management Inc. increased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,510,131 shares of the company’s stock after purchasing an additional 147,054 shares during the period. Charles Schwab Investment Management Inc. owned approximately 1.47% of Option Care Health worth $58,235,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Westfield Capital Management Co. LP boosted its position in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares during the period. Global Alpha Capital Management Ltd. boosted its position in Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after buying an additional 25,905 shares during the period. Graypoint LLC purchased a new position in Option Care Health in the 4th quarter valued at approximately $1,161,000. Victory Capital Management Inc. boosted its position in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares during the period. Finally, Y Intercept Hong Kong Ltd purchased a new position in Option Care Health in the 4th quarter valued at approximately $327,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

Option Care Health stock opened at $32.89 on Thursday. The stock has a market cap of $5.44 billion, a P/E ratio of 27.64, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. The company has a fifty day simple moving average of $30.44 and a 200-day simple moving average of $28.22. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.85. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Wall Street Analysts Forecast Growth

Several brokerages have commented on OPCH. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Finally, Barrington Research lifted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.